PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1370642
PUBLISHER: Global Market Insights Inc. | PRODUCT CODE: 1370642
Biomaterials Market - By Product (Metallic, Polymeric, Ceramic, Natural), By Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Ophthalmology, Wound Healing, Neurology, Tissue Engineering) & Forecast, 2023 - 2032
Global Biomaterials Market will witness over 12.6% CAGR between 2023 and 2032. Increasing investments from promising startups and innovative brands are leading to market growth. For instance, in October 2023, GOZEN, a startup specializing in biomaterials poised to revolutionize the fashion, automotive, and home furnishings sectors, secured $3.3 million in seed funding. This funding round, spearheaded by Happiness Capital, will empower GOZEN to expedite its research, development, and scaling initiatives for its innovative biomaterial, LUNAFORM™. Additionally, it will provide the resources needed to pioneer the creation of new, advanced materials.
These fresh entrants are infusing the industry with novel ideas and groundbreaking technologies. This injection of creativity and capital is driving the development of cutting-edge biomaterials. Therefore, as the industry evolves to meet the demands of various sectors, including healthcare, manufacturing, and beyond, the biomaterials market outlook is set to strengthen.
The overall Biomaterials Market is classified based on product, application, and region.
Polymeric biomaterials segment will undergo significant development from 2023 to 2032. These versatile materials play a pivotal role in various medical applications, from implants to drug delivery systems. Their biocompatibility, tunable properties, and low immunogenicity make them increasingly attractive to medical and healthcare industries. As research and development in polymeric biomaterials advance, the biomaterials market size from this segment is set to continue its growth trajectory.
Ophthalmology segment will register a notable CAGR from 2023 to 2032. This surge is attributed to the development of advanced biomaterials for intraocular lenses, corneal implants, and drug delivery systems. Ophthalmic biomaterials are sought after for their biocompatibility and ability to address vision-related issues with greater precision. As the importance of eye health grows, so does the biomaterials market demand in ophthalmology.
Europe biomaterials market will showcase an appreciable CAGR from 2023 to 2032. Demand for biomaterials, such as biodegradable polymers, tissue engineering scaffolds, and bioactive ceramics, is on the rise. Europe's strong commitment to eco-friendly solutions and advancements in medical technologies is driving the adoption of biomaterials across diverse applications, from medical devices to regenerative medicine, positioning the region as a key player in this market. For instance, in October 2023, FlexSea, a blue biotech firm specializing in the development of bioplastic materials derived from seaweed originating from London, successfully secured €2.3 million in equity funding during its seed round.
Table of Contents
Chapter 1 Methodology & Scope
- 1.1 Market scope & definition
- 1.2 Base estimates & calculations
- 1.3 Forecast parameters
- 1.4 COVID-19 impact analysis
- 1.5 Data validation
- 1.6 Data Sources
- 1.6.1 Primary
- 1.6.2 Secondary
- 1.6.2.1 Paid sources
- 1.6.2.2 Unpaid sources
Chapter 2 Executive Summary
- 2.1 Biomaterials industry 360 degree synopsis, 2018 - 2032
- 2.1.1 Business trends
- 2.1.2 Regional trends
- 2.1.3 Product trends
- 2.1.4 Application trends
Chapter 3 Biomaterials Industry Insights
- 3.1 Industry ecosystem analysis
- 3.2 Industry impact forces
- 3.2.1 Growth drivers
- 3.2.1.1 Increasing demand for biocompatible and biodegradable materials in medical applications
- 3.2.1.2 Growing popularity of tissue engineering
- 3.2.1.3 Advances in nanotechnology and tissue engineering
- 3.2.1.4 Government initiatives to promote the use of biomaterial products
- 3.2.2 Industry pitfalls & challenges
- 3.2.2.1 High development cost for biomaterials
- 3.2.2.2 Biocompatibility and safety concerns
- 3.2.1 Growth drivers
- 3.3 Growth potential analysis
- 3.3.1 By product
- 3.3.2 By application
- 3.4 COVID- 19 impact analysis
- 3.5 Porter's analysis
- 3.6 PESTEL analysis
Chapter 4 Competitive Landscape, 2022
- 4.1 Introduction
- 4.2 Company matrix analysis, 2022
- 4.3 Competitive analysis of major market players, 2022
- 4.4 Competitive positioning matrix, 2022
- 4.5 Strategy dashboard, 2022
Chapter 5 Biomaterials Market Size and Forecast, By Product, 2018 - 2032 (USD Million)
- 5.1 Key trends, by product
- 5.2 Metallic biomaterials
- 5.2.1 Titanium & titanium alloys
- 5.2.2 Stainless steel
- 5.2.3 Silver
- 5.2.4 Cobalt-chrome alloys
- 5.2.5 Gold
- 5.2.6 Magnesium
- 5.3 Polymeric biomaterials
- 5.3.1 Polyester
- 5.3.2 Silicone rubber
- 5.3.3 Polyethylene
- 5.3.4 Polymethymethacrylate
- 5.3.5 Polyetheretherketone
- 5.3.6 Nylon
- 5.3.7 Other polymeric biomaterials
- 5.4 Ceramic biomaterials
- 5.4.1 Calcium phosphate
- 5.4.2 Zirconia
- 5.4.3 Calcium sulfate
- 5.4.4 Carbon
- 5.4.5 Aluminium oxide
- 5.4.6 Glass
- 5.5 Natural biomaterials
- 5.5.1 Hyaluronic acid
- 5.5.2 Collagen
- 5.5.3 Silk
- 5.5.4 Alginates
- 5.5.5 Fibrin
- 5.5.6 Gelatin
- 5.5.7 Cellulose
- 5.5.8 Chitin
Chapter 6 Biomaterials Market Size and Forecast, By Application, 2018 - 2032 (USD Million)
- 6.1 Key trends, by application
- 6.2 Cardiovascular
- 6.2.1 Implantable cardiac defibrillators
- 6.2.2 Pacemakers
- 6.2.3 Stents
- 6.2.4 Vascular grafts
- 6.2.5 Sensors
- 6.2.6 Guidewires
- 6.2.7 Other cardiovascular applications
- 6.3 Ophthalmology
- 6.3.1 Contact lens
- 6.3.2 Intraocular lens
- 6.3.3 Ocular tissue replacement
- 6.3.4 Synthetic corneas
- 6.3.5 Other ophthalmic applications
- 6.4 Dental
- 6.4.1 Dental implants
- 6.4.2 Tissue regeneration materials
- 6.4.3 Bone grafts & substitutes
- 6.4.4 Dental membranes
- 6.4.5 Other dental applications
- 6.5 Orthopedic
- 6.5.1 Joint replacement biomaterials
- 6.5.2 Orthobiologics
- 6.5.3 Bioresorbable tissue fixation products
- 6.5.4 Visco supplementation
- 6.5.5 Spine biomaterials
- 6.5.6 Other orthopedic applications
- 6.6 Wound healing
- 6.6.1 Fracture healing device
- 6.6.2 Adhesion barrier
- 6.6.3 Skin substitutes
- 6.6.4 Internal tissue sealant
- 6.6.5 Surgical hemostats
- 6.6.6 Other wound healing applications
- 6.7 Plastic surgery
- 6.7.1 Soft tissue fillers
- 6.7.2 Facial wrinkle treatment
- 6.7.3 Craniofacial surgery
- 6.7.4 Bioengineered skins
- 6.7.5 Peripheral nerve repair
- 6.7.6 Acellular dermal matrices
- 6.7.7 Other plastic surgery applications
- 6.8 Neurology
- 6.8.1 Neural stem cell encapsulation
- 6.8.2 Shunting systems
- 6.8.3 Hydrogel scaffold for CNS repair
- 6.8.4 Cortical neural prosthetics
- 6.8.5 Other neurology applications
- 6.9 Tissue engineering
- 6.10 Other applications
Chapter 7 Biomaterials Market Size and Forecast, By Region, 2018 - 2032 (USD Million)
- 7.1 Key trends, by region
- 7.2 North America
- 7.2.1 U.S.
- 7.2.2 Canada
- 7.3 Europe
- 7.3.1 Germany
- 7.3.2 UK
- 7.3.3 France
- 7.3.4 Spain
- 7.3.5 Italy
- 7.3.6 Rest of Europe
- 7.4 Asia Pacific
- 7.4.1 Japan
- 7.4.2 China
- 7.4.3 India
- 7.4.4 Australia
- 7.4.5 Rest of Asia Pacific
- 7.5 Latin America
- 7.5.1 Brazil
- 7.5.2 Mexico
- 7.5.3 Rest of Latin America
- 7.6 Middle East & Africa
- 7.6.1 South Africa
- 7.6.2 Saudi Arabia
- 7.6.3 Rest of Middle East & Africa
Chapter 8 Company Profiles
- 8.1 BASF SE
- 8.2 Covestro AG
- 8.3 ROYAL DSM
- 8.4 Celanese Corporation
- 8.5 Carpenter Technology Corporation
- 8.6 Corbion
- 8.7 EVONIK INDUSTRIES
- 8.8 Berkeley Advanced Biomaterials
- 8.9 CAM Bioceramics B.V.
- 8.10 CeramTec GmbH
- 8.11 Noble Biomaterials
- 8.12 Victrex plc.
- 8.13 Mitsubishi Chemical Group Corporation.
- 8.14 CoorsTek Inc.
- 8.15 Zeus Company Inc.
